Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 13, 2026, titled ""Dr. Reddy s announces the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulifr, in the United States."".